Interventions for the reduction of prescribed opioid use in chronic non-cancer pain

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 9, 2013, Pages

  Windmill, Jude ^a   Fisher, Emma ^b   Eccleston, Christopher ^b   Derry, Sheena ^a   Stannard, Cathy ^c   Knaggs, Roger ^d   Moore, R Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b University of Bath   (United Kingdom)

^c FRENCHAY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; ANALGESIC AGENT; OPIATE; PLACEBO; PRESCRIPTION DRUG;

CHRONIC PAIN; COGNITIVE BEHAVIORAL THERAPY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ELECTROACUPUNCTURE; HUMAN; INTERACTIVE VOICE RESPONSE SYSTEM; INTERMETHOD COMPARISON; INTERVENTION STUDY; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADVERSE EVENT; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COPING BEHAVIOR; FOLLOW UP; FUNCTIONAL ASSESSMENT; MASSAGE; META ANALYSIS; PATIENT COUNSELING; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; DRUG TOLERANCE; METHODOLOGY; OBSERVATIONAL STUDY; PROCEDURES;

ANALGESICS, OPIOID; CHRONIC PAIN; COGNITIVE THERAPY; DRUG TOLERANCE; ELECTROACUPUNCTURE; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THERAPY, COMPUTER-ASSISTED;

EID: 85041952283     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010323.pub2     Document Type: Review

References (46)

1. Naylor MR, Keefe FJ, Brigidi B, Naud S, Helzer JE. Therapeutic Interactive Voice Response for chronic pain reduction and relapse prevention. Pain 2008;134(3):335-45. [DOI: 10.1016/j.pain.2007.11.001]
2. Naylor MR, Naud S, Keefe FJ, Helzer JE. Therapeutic interactive voice response (TIVR) to reduce analgesic medication use for chronic pain management. The Journal of Pain 2010;11(12):1410-9. [DOI: 10.1016/j.jpain.2010.03.019]
3. Zheng Z, Gue RJ, Helme RD, Muir A, Costa CD, Xue CCL. The effect of electroacupuncture on opioid-like medication consumption by chronic pain patients: a pilot randomized controlled trial. European Journal of Pain 2008;12:671-6. [DOI: 10.1016/j.ejpain.2007.10.003]
4. Crisostomo RA, Schmidt JE, Hooten WM, Kerkvliet JL, Townsend CO, Bruce BK. Withdrawal of analgesic medication for chronic low-back pain patients: improvement in outcomes of multidisciplinary rehabilitation regardless of surgical history. American Journal of Physical Medicine and Rehabilitation 2008;87(7):527-36. [DOI: 10.1097/PHM.0b013e31817c124f]
5. Hale ME, Ahdieh H, Ma T, Rauck R. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. The Journal of Pain 2007;8(2):175-84. [DOI: 10.1016/j.jpain.2006.09.011]
6. Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 2003;23:982-93. [DOI: 10.1046/j.1468-2982.2003.00648.x]
7. Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the clinical trials network. Journal of Substance Abuse Treatment 2010;38 (Suppl 1):S80-6. [DOI: 10.1016/j.jsat.2009.12.007]
8. ®, an extended-release formulation of oxycodone. Postgraduate Medicine 2011;123(4):148-59. [DOI: 10.3810/pgm.2011.07.2314]
9. Townsend CO, Kerkvliet JL, Bruce BK, Rome JD, Hooten WM, Luedtke CA, et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Pain 2008;140(1):177-89. [DOI: 10.1016/j.pain.2008.08.005]
10. Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Clinical Therapeutics 2006;28(1):86-98. [DOI: 10.1016/j.clinthera.2006.01.010]
11. Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD005031.pub4]
12. Manchikanti L, Abdi S, Atluri S, Balog C, Benyamin R, Boswell M, et al. American Society of Interventional Pain Physicians (AISPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 1-evidence assessment. Pain Physician 2012;15 (3 Suppl):S1-65.
13. Atluri S, Akbik H, Sudarshan G. Prevention of opioid abuse in chronic non-cancer pain: an algorithmic, evidence based approach. Pain Physician 2012;15(3 Suppl):ES177-89.
14. Ballantyne JC, Mao J. Opioid therapy for chronic pain. New England Journal of Medicine 2003;349(20):1943-53. [DOI: 10.1056/NEJMra025411]
15. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician 2008;11(2 Suppl):S105-20.
16. British Pain Society, the Faculty of Pain Medicine of the Royal College of Anaesthetists, the Royal College of General Practitioners and the Faculty of Addictions of the Royal College of Psychiatrists. Opioids for persistent pain: good practice, 2010. http://www.britishpainsociety.org/pub_professional.htm (accessed 15 April 2013). London: The British Pain Society. [ISBN: 978-0-9561386-0-6]
17. Braden JB, Russo J, Fan MY, Edlund MJ, Martin BC, DeVries A, et al. Emergency department visits among recipients of chronic opioid therapy. Archives of Internal Medicine 2010;170(16):1425-32. [DOI: 10.1001/archinternmed.2010.273]
18. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic non cancer pain. Journal of Pain 2009;10(2):113-30. [DOI: 10.1016/j.jpain.2008.10.009]
19. Darchuk KM, Townsend CO, Rome JD, Bruce BK, Hooten WM. Longitudinal treatment outcomes for geriatric patients with chronic non-cancer pain at an interdisciplinary pain rehabilitation program. Pain Medicine 2010;11(9):1352-64. [DOI: 10.1111/j.1526-4637.2010.00937.x]
20. Department of Labor & Industries. Interim evaluation of the Washington State interagency guideline on opioid dosing for chronic non-cancer pain, 2009. http://www.agencymeddirectors.wa.gov/Files/AGReportFinal.pdf (accessed 24 April 2013).
21. Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. American Journal of Industrial Medicine 2012;55(4):325-31. [DOI: 10.1002/ajim.21998]
22. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic non-cancer pain: a meta-analysis of effectiveness and side effects. Canadian Medical Association Journal 2006;174(11):1589-94. [DOI: 10.1503/cmaj.051528]
23. Gallagher AM, Leighton-Scott J, van Staa TP. Utilization characteristics and treatment persistence in patients prescribed low-dose buprenorphine patches in primary care in the United Kingdom: a retrospective cohort study. Clinical Therapeutics 2009;31(8):1707-15. [DOI: 10.1016/j.clinthera.2009.08.022]
24. Gowing L, Ali R, White JM. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD002021.pub3]
25. Gowing L, Ali R, White JM. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD002022.pub3]
26. State of Washington. Engrossed Substitute House Bill 2876, 2010. http://apps.leg.wa.gov/documents/billdocs/2009-10/Pdf/Bills/House%20Bills/2876-S.E.pdf (accessed 24 April 2013).
27. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Medicine 2007;8(1):8-16. [DOI: 10.1111/j.1526-4637.2007.00253.x]
28. Hooten WM, Townsend CO, Bruce BK, Warner DO. The effects of smoking status on opioid tapering among patients with chronic pain. Anesthesia and Analgesia 2009;108(1):308-15. [DOI: 10.1213/ane.0b013e31818c7b99]
29. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112(3):372-80. [DOI: 10.1016/j.pain.2004.09.019]
30. Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Internal Medical Journal 2009;39(10):676-81. [DOI: 10.1111/j.1445-5994.2009.01982.x]
31. Anon. Pain Rehabilitation Center in Minnesota, 2013. www.mayoclinic.org/pain-rehabilitation-center-rst/threeweekprc.html (accessed 13 April 2013).
32. McDonough M. Safe prescribing of opioids for persistent non-cancer pain. Australian Prescriber 2012;35(1):20-4.
33. Miller M, Stürmer T, Azrael D, Levin R, Solomon DH. Opioid analgesics and the risk of fractures in older adults with arthritis. Journal of the American Geriatrics Society 2011;59:430-8. [DOI: 10.1111/j.1532-5415.2011.03318.x]
34. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Research and Therapy 2005;7(5):R1046-51. [DOI: 10.1186/ar1782]
35. Moore RA, Straube S, Eccleston C, Derry S, Aldington D, Wiffen P, et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain 2012;153(2):265-8. [DOI: 10.1016/j.pain.2011.10.004]
36. Moore RA, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice 2013;epub March 6. [DOI: 10.1111/papr.12050]
37. Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain 2010;151(3):625-32. [DOI: 10.1016/j.pain.2010.08.002]
38. NHS Information Centre. A repository of prescribing data, extracted from 'NHS Information Centre'. http://www.ic.nhs.uk/statistics-and-data-collections/primary-care/prescriptions 2004-2012 (accessed 15 April 2013).
39. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006605.pub2]
40. Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: overdoses of prescription opioid pain relievers, United States, 1999-2008. Morbidity and Mortality Weekly Report 2011;60(43):1487-92.
41. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Archives of Internal Medicine 2010;170(1):1968-76. [DOI: 10.1001/archinternmed.2010.391]
42. Stannard C. Opioid prescribing in the UK: can we avert a public health disaster?. British Journal of Pain 2012;6(1):7-8. [DOI: 10.1177/2049463712439131]
43. Steiner DJ, Sitar S, Wen W, Sawyerr G, Munera C, Ripa SR, et al. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study. Journal of Pain Symptom Management 2011;42(6):903-17. [DOI: 10.1016/j.jpainsymman.2011.04.006]
44. Sullivan MD, Edlund MJ, Fan M, Devries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP study. Pain 2010;150(2):332-9. [DOI: 10.1016/j.pain.2010.05.020]
45. Washington State Agency Medical Director's Group. Interagency guideline on opioid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy, 2010. www.agencymeddirectors.wa.gov/(accessed 15 April 2013).
46. Williams ACDC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD007407.pub3]